EW
Ticker
Edwards Lifesciences Corp
Company
Devices
Industry
Healthcare
Sector
+
2009
+
2010
+
2011
+
2012
+
2013
+
2014
+
2015
+
2016
+
2017
+
2018
+
2019
+
2020
+
2021
+
2022
+
2023
+
2024
+
2025
TTM
Revenue Growth YoY
9.5%16.0%13.2%7.7%13.6%7.4%18.8%15.9%8.4%16.8%0.9%19.3%2.9%11.6%-9.4% 5.3%
Revenue Growth QoQ
Gross Margin
69.8%71.8%70.8%74.0%74.7%73.1%75.2%73.1%74.5%74.8%74.4%75.4%76.1%79.9%77.0%79.5% 78.2%
EBITDA Margin
27.3%22.0%20.0%23.7%28.4%53.0%28.1%27.7%34.1%22.2%28.4%22.9%34.9%35.1%28.0%28.2% 26.9%
Operating Margin
22.8%18.1%16.6%20.7%25.3%50.0%25.5%25.3%31.7%20.1%26.4%20.5%32.3%32.5%25.5%25.3% 24.2%
Profit Margin
17.3%15.1%14.1%15.4%19.0%34.9%19.8%19.2%17.0%19.4%24.1%18.8%28.7%28.3%23.4%76.7% 23.2%
FCF / EBITDA
28.1%59.2%66.5%54.7%62.5%75.4%63.2%59.2%70.5%83.0%73.2%64.4%76.8%50.5%37.5%16.9% 50.5%